$1.27
-0.035-2.68%
Last update: Oct 22, 4:00 PM
PMV Pharmaceuticals Inc (PMVP) Stock Price, Quote, News & History
PMVPNASDAQ
PMV Pharmaceuticals reports 46% ORR in Phase 2 trial for ovarian cancer drug rezatapopt. NDA submission planned for Q1 2027.
You can purchase shares of PMV Pharmaceuticals (NASDAQ:PMVP) through any online brokerage.
Other companies in PMV Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
PMV Pharmaceuticals has a consensus price target of $5.17.
The stock price for PMV Pharmaceuticals (NASDAQ: PMVP) is $1.305 last updated October 22, 2026 at 4:00 PM EDT.
There are no upcoming dividends for PMV Pharmaceuticals.
PMV Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for PMV Pharmaceuticals.
PMV Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate,...
